Clinical Outcomes and Cost-effectiveness of Continuous Positive Airway Pressure to Manage Obstructive Sleep Apnea in Patients With Type 2 Diabetes in the U.K.
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess clinical outcomes and cost-effectiveness of using continuous positive airway pressure (CPAP) to manage obstructive sleep apnea (OSA) in patients with type 2 diabetes (T2D) from the perspective of the U.K.’s National Health Service (NHS). RESEARCH DESIGN AND METHODS: Using a case-control design, 150 CPAP-treated patients with OSA and T2D were randomly selected from The Health Improvement Network (THIN) database (a nationally representative database of patients registered with general practitioners in the U.K.) and matched with 150 OSA and T2D patients from the same database who were not treated with CPAP. The total NHS cost and outcomes of patient management in both groups over 5 years and the cost-effectiveness of CPAP compared with no CPAP treatment were estimated. RESULTS: Using CPAP was associated with significantly lower blood pressure at 5 years and increasingly lower HbA1c levels over 5 consecutive years compared with untreated OSA patients. At 5 years, the HbA1c level in the CPAP-treated group was 8.2% (66.0 mmol/mol) vs. 12.1% (108.4 mmol/mol) in the control group (P < 0.03). Use of CPAP significantly increased patients’ health status by 0.27 quality-adjusted life years (QALYs) per patient over 5 years (P < 0.001) and NHS management costs by £4,141 per patient over 5 years; the cost per QALY gained with CPAP was £15,337. CONCLUSIONS: Initiating treatment with CPAP in OSA patients with T2D leads to significantly lower blood pressure and better controlled diabetes and affords a cost-effective use of NHS resources. These observations have the potential for treatment modification if confirmed in a prospective study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spiegel, K., Leproult, R., L’Hermite-Balériaux, M., Copinschi, G., Penev, P. D., & Van Cauter, E. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1003 · Cited by 1,006 · cited 1×
“Chronic sleep loss, a consequence of OSA, is also associated with decreased glucose tolerance, decreased leptin, and an increase in evening cortisol levels (10,11).”
BackgroundHigh prevalence of unrecognized sleep apnoea in drug-resistant hypertension
Logan, A. G., Perlikowski, S. M., Mente, A., Tisler, A., Tkacova, R., Niroumand, M., Leung, R. S. T., & Bradley, T. D. (2001) · Journal of Hypertension · doi:10.1097/00004872-200112000-00022 · Cited by 960 · cited 1×
“OSA is also linked to drug-resistant hypertension (9).”
BackgroundBlak, B., Thompson, M., Dattani, H., & Bourke, A. (2011) · Journal of Innovation in Health Informatics · doi:10.14236/jhi.v19i4.820 · Cited by 630
Harsch, I. A., Schahin, S. P., Radespiel-Tröger, M., Weintz, O., Jahreiß, H., Fuchs, F. S., Wiest, G. H., Hahn, E. G., Lohmann, T., Konturek, P. C., et al. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-206oc · Cited by 583
Babu, A. R., Herdegen, J., Fogelfeld, L., Shott, S., & Mazzone, T. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.4.447 · Cited by 453 · cited 2×
“The short-term effect of CPAP treatment on diabetes is controversial, with some studies reporting an improvement in insulin sensitivity (18–20) and a reduction in HbA1c levels (21,22), while others have reported no effect (23).”
BackgroundWest, S. D., Nicoll, D. J., Wallace, T. M., Matthews, D. R., & Stradling, J. R. (2007) · Thorax · doi:10.1136/thx.2006.074351 · Cited by 408 · cited 1×
“The short-term effect of CPAP treatment on diabetes is controversial, with some studies reporting an improvement in insulin sensitivity (18–20) and a reduction in HbA1c levels (21,22), while others have reported no effect (23).”
BackgroundSelf-citationObstructive Sleep Apnea and Type 2 Diabetes
Tasali, E., Mokhlesi, B., & Van Cauter, E. (2008) · Chest · doi:10.1378/chest.07-0828 · Cited by 371
Prevalence of Sleep Apnea in a Population of Adults with Type 2 Diabetes Mellitus
Einhorn, D., Stewart, D. A., Erman, M. K., Gordon, N., Philis-Tsimikas, A., & Casal, E. (2007) · Endocrine Practice · doi:10.4158/ep.13.4.355 · Cited by 232 · cited 1×
“The prevalence of moderate OSA in patients with T2D has been reported to be 49% of men and 21% of women (14).”
BackgroundHarsch, I. A., Schahin, S. P., Brückner, K., Radespiel-Tröger, M., Fuchs, F. S., Hahn, E. G., Konturek, P. C., Lohmann, T., & Ficker, J. H. (2004) · Respiration · doi:10.1159/000077423 · Cited by 219
Cited by
Obstructive Sleep Apnea and Diabetes
Reutrakul, S., & Mokhlesi, B. (2017) · Chest · doi:10.1016/j.chest.2017.05.009 · Cited by 667
Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome
Knauert, M., Naik, S., Gillespie, M. B., & Kryger, M. (2015) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1016/j.wjorl.2015.08.001 · Cited by 295
Frailty, Sarcopenia and Diabetes
Morley, J. E., Malmstrom, T. K., Rodriguez-Mañas, L., & Sinclair, A. J. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.10.001 · Cited by 277
Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008?
Siegel, K. R., Ali, M. K., Zhou, X., Ng, B. P., Jawanda, S., Proia, K., Zhang, X., Gregg, E. W., Albright, A. L., & Zhang, P. (2020) · Diabetes Care · doi:10.2337/dci20-0017 · Cited by 164
The Impact of Treatments for OSA on Monetized Health Economic Outcomes
Wickwire, E. M., Albrecht, J. S., Towe, M. M., Abariga, S. A., Diaz-Abad, M., Shipper, A. G., Cooper, L. M., Assefa, S. Z., Tom, S. E., & Scharf, S. M. (2019) · Chest · doi:10.1016/j.chest.2019.01.009 · Cited by 88
Sleep-disordered breathing, type 2 diabetes and the metabolic syndrome
Seetho, I. W., & Wilding, J. P. (2014) · Chronic Respiratory Disease · doi:10.1177/1479972314552806 · Cited by 57
Streatfeild, J., Hillman, D., Adams, R., Mitchell, S., & Pezzullo, L. (2019) · Sleep · doi:10.1093/sleep/zsz181 · Cited by 51
Kempfle, J. S., BuSaba, N. Y., Dobrowski, J. M., Westover, M. B., & Bianchi, M. T. (2017) · The Laryngoscope · doi:10.1002/lary.26257 · Cited by 30
Smyth, A., Jenkins, M., Dunham, M., Kutzer, Y., Taheri, S., & Whitehead, L. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108532 · Cited by 28
Self-citation
Metadata
- Authors
- Guest, J. F., Panca, M., Sladkevicius, E., Taheri, S., & Stradling, J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2014-04-10
- Volume
- 37
- Issue
- 5
- Pages
- 1263-1271
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2150874181
- Cited by
- 72
- References
- 12
- FWCI
- 6.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.